Comparison of Tegoprazan- and Lansoprazole-Based Fourteen-Day Triple Therapies as First-Line Treatments for Eradication

• Main Authors: Seokin Kang (Author), Nam-Hoon Kim (Author), Seokhyeon Jeong (Author), Jong Wook Kim (Author), Jung Rock Moon (Author), Yoon Suk Lee (Author), Jun Hyuk Son (Author)
• Format: Book
• Published: Yong Chan Lee, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objectives Tegoprazan, a novel potassium-competitive acid blocker with rapid and effective antisecretory activity, was approved for the treatment of Helicobacter pylori infections in Korea in March 2020. However, real-world data regarding tegoprazan-based therapies are scarce. We compared the effica...